Unidade de investigación

2024

1. A new BRAF inhibitor breaks resistance barriers

   Trends in Cancer

2. Antibiotic Use and Antimicrobial Resistance: A Global Public Health Crisis

   Antibiotics

3. Author's reply: “Enhancing colorectal cancer (CLC) research: Insights & areas for improvement”

   Digestive and Liver Disease

4. Comparison of tracheal intubation conditions between the operating room and intensive care unit: impact of universal videolaryngoscopy

   British Journal of Anaesthesia

5. Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury

   Nature Aging

6. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

   Molecular & cellular proteomics : MCP

7. Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions” [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150] (International Journal of Antimicrobial Agents (2024) 63(5), (S0924857924000682), (10.1016/j.ijantimicag.2024.107150))

   International Journal of Antimicrobial Agents

8. Erratum: Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae: interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications" (Antimicrobial agents and chemotherapy (2024) 68 5 DOI: 10.1128/aac.01315-23)

   Antimicrobial agents and chemotherapy

9. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

   Clinical Microbiology and Infection